Molecular and Cellular Biochemistry

, Volume 400, Issue 1–2, pp 201–206 | Cite as

Endothelial progenitor cells proliferated via MEK-dependent p42 MAPK signaling pathway

  • Ferry Sandra
  • Yudi Her Oktaviono
  • Mohammad Aris Widodo
  • Yanni Dirgantara
  • Angliana Chouw
  • Djanggan Sargowo
Article

Abstract

Endothelial progenitor cells (EPCs) clinical applications have been well reported. However, due to low number of EPCs that could be isolated, EPCs expansion study became one of the main focuses. Some optimized mediums to culture EPCs were currently available. However, the proliferation signaling pathway is not clearly disclosed yet. Peripheral blood was collected from eight healthy subjects, followed by mononuclear cells (MNCs) isolation. MNCs were then prepared and cultured for 2 days. After that, non-adherent cells were harvested and further cultured for 3 days. Resulted colony-forming unit (CFU)-Hill colonies were documented and enumerated under an inverted light microscope. To detect membrane markers, immunofluorescence was performed to detect CD34, VEGFR-2, and CD133. Cell documentation was conducted under a fluorescence microscope. To check cell proliferation, XTT Cell Proliferation Assay Kit was used according to kit insert. To detect possible activation of p44/42 MAPK, western blot was performed to detect p44/42 MAPK and phosphorylated p44/42 MAPK. All visualized bands were captured and quantified. Our results showed that EPCs markers (CD34, CD133 and VEGFR-2) were detected in 3 days culture. From XTT cell proliferation assay and CFU enumeration results, we found that EPCs proliferated significantly (p = 0.012) with addition of supplement. Phosphorylated-p42 MAPK expression of EPCs treated with supplement was significantly higher than the one of EPCs without treatment. Significant inhibition of p42 MAPK phosphorylation by U0126 was observed (p = 0.012). By pretreatment of U0126, number of viable cells and CFUs treated with supplement was significantly decreased (p = 0.012). Our results showed that MEK-dependent p42 MAPK pathway might play an important role in EPCs proliferation.

Keywords

Endothelial progenitor cell EPC p42 Erk2 MAPK Proliferation 

References

  1. 1.
    Lois N, McCarter RV, O’Neill C, Medina RJ, Stitt AW (2014) Endothelial Progenitor Cells in Diabetic Retinopathy. Front Endocrinol (Lausanne) 5:44. doi:10.3389/fendo.2014.00044 Google Scholar
  2. 2.
    Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, Witzenbichler B, Schatteman G, Isner JM (1997) Isolation of putative progenitor endothelial cells for angiogenesis. Science 275:964–967CrossRefPubMedGoogle Scholar
  3. 3.
    Schmidt-Lucke C, Fichtlscherer S, Aicher A, Tschöpe C, Schultheiss HP, Zeiher AM, Dimmeler S (2010) Quantification of circulating endothelial progenitor cells using the modified ISHAGE protocol. PLoS One 5:e13790. doi:10.1371/journal.pone.0013790 PubMedCentralCrossRefPubMedGoogle Scholar
  4. 4.
    Kawamoto A, Losordo DW (2008) Endothelial progenitor cells for cardiovascular regeneration. Trends Cardiovasc Med 18:33–37. doi:10.1016/j.tcm.2007.11.004 PubMedCentralCrossRefPubMedGoogle Scholar
  5. 5.
    Britten MB, Abolmaali ND, Assmus B, Lehmann R, Honold J, Schmitt J, Vogl TJ, Martin H, Schächinger V, Dimmeler S, Zeiher AM (2003) Infarct remodeling after intracoronary progenitor cell treatment in patients with acute myocardial infarction (TOPCARE-AMI): mechanistic insights from serial contrast-enhanced magnetic resonance imaging. Circulation 108:2212–2218CrossRefPubMedGoogle Scholar
  6. 6.
    Tanaka R, Masuda H, Kato S, Imagawa K, Kanabuchi K, Nakashioya C, Yoshiba F, Fukui T, Ito R, Kobori M, Wada M, Asahara T, Miyasaka M (2014) Autologous G-CSF-mobilized peripheral blood CD34+ cell therapy for diabetic patients with chronic nonhealing ulcer. Cell Transplant 23:167–179. doi:10.3727/096368912X658007 CrossRefPubMedGoogle Scholar
  7. 7.
    Grisar JC, Haddad F, Gomari FA, Wu JC (2011) Endothelial progenitor cells in cardiovascular disease and chronic inflammation: from biomarker to therapeutic agent. Biomark Med 5:731–744. doi:10.2217/bmm.11.92 PubMedCentralCrossRefPubMedGoogle Scholar
  8. 8.
    Fabbri-Arrigoni FI, Clarke L, Wang G, Charakida M, Ellins E, Halliday N, Brogan PA, Deanfield JE, Halcox JP, Klein N (2012) Levels of circulating endothelial cells and colony-forming units are influenced by age and dyslipidemia. Pediatr Res 72:299–304. doi:10.1038/pr.2012.76 PubMedCentralCrossRefPubMedGoogle Scholar
  9. 9.
    Campioni D, Zauli G, Gambetti S, Campo G, Cuneo A, Ferrari R, Secchiero P (2013) In vitro characterization of circulating endothelial progenitor cells isolated from patients with acute coronary syndrome. PLoS One 8:e56377. doi:10.1371/journal.pone.0056377 PubMedCentralCrossRefPubMedGoogle Scholar
  10. 10.
    Cribbs SK, Sutcliffe DJ, Taylor WR, Rojas M, Easley KA, Tang L, Brigham KL, Martin GS (2012) Circulating endothelial progenitor cells inversely associate with organ dysfunction in sepsis. Intensive Care Med 38:429–436. doi:10.1007/s00134-012-2480-9 PubMedCentralCrossRefPubMedGoogle Scholar
  11. 11.
    Khoo CP, Pozzilli P, Alison MR (2008) Endothelial progenitor cells and their potential therapeutic applications. Regen Med 3:863–876. doi:10.2217/17460751.3.6.863 CrossRefPubMedGoogle Scholar
  12. 12.
    Meier P, Gloekler S, Oezdemir B, Indermuehle A, Traupe T, Vogel R, de Marchi S, Seiler C (2013) G-CSF induced arteriogenesis in humans: molecular insights into a randomized controlled trial. Curr Vasc Pharmacol 11:38–46CrossRefPubMedGoogle Scholar
  13. 13.
    Kimura H, Okubo N, Chosa N, Kyakumoto S, Kamo M, Miura H, Ishisaki A (2013) EGF positively regulates the proliferation and migration, and negatively regulates the myofibroblast differentiation of periodontal ligament-derived endothelial progenitor cells through MEK/ERK- and JNK-dependent signals. Cell Physiol Biochem 32:899–914. doi:10.1159/000354493 CrossRefPubMedGoogle Scholar
  14. 14.
    Takahashi M, Okubo N, Chosa N, Takahashi N, Ibi M, Kamo M, Mizuki H, Ishisaki A, Kyakumoto S (2012) Fibroblast growth factor-1-induced ERK1/2 signaling reciprocally regulates proliferation and smooth muscle cell differentiation of ligament-derived endothelial progenitor cell-like cells. Int J Mol Med 29:357–364. doi:10.3892/ijmm.2011.847 PubMedGoogle Scholar
  15. 15.
    Qiu C, Xie Q, Zhang D, Chen Q, Hu J, Xu L (2014) GM-CSF Induces Cyclin D1 Expression and Proliferation of Endothelial Progenitor Cells via PI3 K and MAPK Signaling. Cell Physiol Biochem 33:784–795. doi:10.1159/000358652 CrossRefPubMedGoogle Scholar
  16. 16.
    Yang L, Guo XG, Du CQ, Yang JX, Jiang DM, Li B, Zhou WJ, Zhang FR (2012) Interleukin-1 beta increases activity of human endothelial progenitor cells: involvement of PI3K-Akt signaling pathway. Inflammation 35:1242–1250. doi:10.1007/s10753-012-9434-9 CrossRefPubMedGoogle Scholar
  17. 17.
    Katz M, Amit I, Yarden Y (2007) Regulation of MAPKs by growth factors and receptor tyrosine kinases. Biochim Biophys Acta 1773:1161–1176PubMedCentralCrossRefPubMedGoogle Scholar
  18. 18.
    Graves LM, Guy HI, Kozlowski P, Huang M, Lazarowski E, Pope RM, Collins MA, Dahlstrand EN, Earp HS 3rd, Evans DR (2000) Regulation of carbamoyl phosphate synthetase by MAP kinase. Nature 403:328–332CrossRefPubMedGoogle Scholar
  19. 19.
    Vantaggiato C, Formentini I, Bondanza A, Bonini C, Naldini L, Brambilla R (2006) ERK1 and ERK2 mitogen-activated protein kinases affect Ras-dependent cell signaling differentially. J Biol 5:14PubMedCentralCrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  • Ferry Sandra
    • 1
    • 2
  • Yudi Her Oktaviono
    • 3
    • 4
  • Mohammad Aris Widodo
    • 4
    • 5
  • Yanni Dirgantara
    • 6
  • Angliana Chouw
    • 6
  • Djanggan Sargowo
    • 4
    • 7
  1. 1.Prodia Clinical LaboratoryJakartaIndonesia
  2. 2.Department of Biochemistry and Molecular Biology, Faculty of DentistryTrisakti UniversityJakartaIndonesia
  3. 3.Department of Cardiology and Vascular Medicine, Faculty of Medicine, Dr. Soetomo HospitalUniversity of AirlanggaSurabayaIndonesia
  4. 4.Postgraduate Program in Biomedical Sciences, Faculty of MedicineBrawijaya UniversityMalangIndonesia
  5. 5.Department of Pharmacology, Faculty of MedicineBrawijaya UniversityMalangIndonesia
  6. 6.PT. Prodia Stemcell IndonesiaJakartaIndonesia
  7. 7.Department of Cardiology and Vascular Medicine, Faculty of Medicine, Dr. Saiful Anwar General HospitalBrawijaya UniversityMalangIndonesia

Personalised recommendations